McKesson’s proactive approach to drug supply constraints: 3 insights

Healthcare supplier McKesson formed a Critical Care Drug Task Force to proactively manage pharmaceutical supply constraints during the pandemic, according to an Oct. 27 announcement.

Advertisement

What you should know:

1. The task force compares the number of COVID-19 cases on local and national levels with customer demand patterns to forecast supply needs for pharmaceutical manufacturers.

2. The strategy was developed in response to pandemic-induced purchasing increases and is intended to help hospital customers remain prepared to treat COVID-19 patients.

3. The cross-functional team will continue meeting indefinitely.

More articles on surgery centers:
The ASC in 2021: 3 expert predictions on cardiology
10 lowest-paying cities for physicians
ASC valuation multiples continue to rise & more — 12 ASC industry notes

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.